A
$ Value
$0
Shares
95,000
Price
$0
Filed
Mar 20
Insider
Name
Gall Matthew
Title
Chief Financial Officer
CIK
0001816194
Roles
Officer
Transaction Details
Transaction Date
2026-03-19
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
95,000
Footnotes
The option was granted on March 19, 2026. The shares underlying the option are scheduled to vest over four years, with 25% of the shares underlying the option vesting on March 19, 2027, and the remainder vesting in equal monthly installments thereafter, subject to continuous service.
Filing Info
Gall Matthew's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-19 | KLRS | A | $0 |
| 2025-11-03 | KLRS | A | $0 |
| 2025-08-29 | ITOS | U | — |
| 2025-08-29 | ITOS | D | — |
| 2025-08-29 | ITOS | D | — |
| 2025-08-29 | ITOS | D | — |
| 2025-08-29 | ITOS | D | — |
| 2025-08-29 | ITOS | D | — |
Other Insiders at KLRS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| AKKARAJU SRINIVAS | $5.0M | — | 2025-12-18 |
|
Hagen Brett R
Chief Accounting Officer
|
— | $13K | 2026-03-20 |
|
Feinsod Matthew
Chief Medical Officer
|
— | — | 2026-03-19 |
|
Oxtoby Andrew
See Remarks
|
— | — | 2026-03-19 |